April 18, 2019 — A recent study found patients with atherosclerotic cardiovascular disease cut their risk of a second ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
April 18, 2019
April 16, 2019 — HonorHealth Research Institute announced the first patients have been enrolled in the SynIVUS-DAPT ...
April 16, 2019
April 15, 2019 — Despite national guidelines indicating statins can lower risk of heart attack and stroke, many patients ...
April 15, 2019
April 9, 2019 — A program designed to help heart attack patients with the transition from hospital to outpatient care ...
April 09, 2019
April 5, 2019 — Three years ago this week, Abiomed's Impella heart pump received U.S. Food and Drug Administration (FDA) ...
April 05, 2019
April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut ...
April 03, 2019
April 2, 2019 — A Swedish review of out-of-hospital cardiac arrest data shows rates of bystander cardiopulmonary ...
April 02, 2019
March 29, 2019 — The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of ...
March 29, 2019
March 29, 2019 — A research team from Imperial College London believes a new software could speed up the diagnosis and ...
March 29, 2019
March 29, 2019 — Taking a high dose of icosapent ethyl significantly reduces the occurrence of first, subsequent and ...
March 29, 2019
Interview with Frederick Masoudi, M.D., FACC, FAHA, professor of cardiology at the University of Colorado Hospital, and ...
March 28, 2019
March 27, 2019 — Training interventional radiologists to perform endovascular thrombectomies results in positive ...
March 27, 2019![New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/valsartan (Entresto) continued to deliver reductions in the heart failure biomarker N-terminal pro–B-type natriuretic peptide (NT-proBNP), an established biomarker for heart failure severity and prognosis.[1] The data was presented as a late-breaker at the American College of Cardiology (ACC) 2019 Annual Scientific Session in March.](/sites/default/files/styles/content_feed_medium/public/Entresto_bottles.jpg?itok=sp56E5GI)
March 27, 2019 —New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril ...
March 27, 2019
March 25, 2019 — Patients who stopped taking aspirin one month after receiving a stent in the heart’s arteries but ...
March 25, 2019
March 25, 2019 — Phase 3 results from Study 2, also known as CLEAR WISDOM, of bempedoic acid were recently presented at ...
March 25, 2019